C07K 14/47
From mammals
Official title: from mammals
C07K14/47 (From mammals) appears on 17,873 US grants and 27,452 published applications in this corpus.
Search patents in C07K- Granted patents
- 17,873
- Published applications
- 27,452
- Assignees
- 6,681
- Inventors
- 39,553
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 12 | 0 |
| 1982 | 7 | 0 |
| 1983 | 7 | 0 |
| 1984 | 12 | 0 |
| 1985 | 13 | 0 |
| 1986 | 10 | 0 |
| 1987 | 13 | 0 |
| 1988 | 20 | 0 |
| 1989 | 24 | 0 |
| 1990 | 26 | 0 |
| 1991 | 35 | 0 |
| 1992 | 58 | 0 |
| 1993 | 109 | 0 |
| 1994 | 109 | 0 |
| 1995 | 126 | 0 |
| 1996 | 213 | 0 |
| 1997 | 385 | 0 |
| 1998 | 698 | 0 |
| 1999 | 719 | 0 |
| 2000 | 609 | 0 |
| 2001 | 645 | 116 |
| 2002 | 591 | 1380 |
| 2003 | 566 | 3500 |
| 2004 | 526 | 1476 |
| 2005 | 474 | 1369 |
| 2006 | 680 | 1149 |
| 2007 | 750 | 942 |
| 2008 | 680 | 835 |
| 2009 | 538 | 948 |
| 2010 | 588 | 877 |
| 2011 | 567 | 824 |
| 2012 | 430 | 697 |
| 2013 | 498 | 714 |
| 2014 | 452 | 816 |
| 2015 | 510 | 807 |
| 2016 | 541 | 884 |
| 2017 | 545 | 785 |
| 2018 | 542 | 920 |
| 2019 | 609 | 986 |
| 2020 | 635 | 1043 |
| 2021 | 663 | 1119 |
| 2022 | 613 | 1203 |
| 2023 | 490 | 1100 |
| 2024 | 597 | 1202 |
| 2025 | 558 | 1044 |
| 2026 | 349 | 716 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Microdystrophin nucleic acid gene therapy constructs and uses thereof6 Oct 2026US 12,752,020 B2REGENXBIO Inc.
- Methods of manufacturing microdystrophin gene therapy constructs6 Oct 2026US 12,752,021 B2REGENXBIO Inc.
- Protein with anti-inflammatory properties6 Oct 2026US 12,753,214 B2Revolo Biotherapeutics Limited
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Polymer-based therapeutics for inductive browning of fat8 Oct 2026US 2026/0306643 A1Purdue Research Foundation
Most cited
By later US patents
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites556US 6,453,242 B1Sangamo BioSciences, Inc. · 2002
- Isolation of exogenous recombinant proteins from the milk of transgenic mammals500US 4,873,316 ABiogen, Inc. · 1989
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Binding proteins for recognition of DNA434US 6,007,988 AMedical Research Council · 1999